Marilena Vrana/LinkedIn
Dec 15, 2025, 13:04
Ahead of IPPC2026: Marilena Vrana Reflects on Powering Possibility for All Patients
Marilena Vrana, Vice President at the Plasma Protein Therapeutics Association (PPTA) Europe, shared on LinkedIn:
“Why do collective strength and shared responsibility matter more than ever to power possibility for all patients?
Ahead of IPPC2026 (April 28-29, Milan), this article reflects on where we stand today and the issues that will shape discussion as we look ahead.
Meet me in Milan to continue the conversation”
Get the latest hemostasis insights with Hemostasis Today.
-
May 9, 2026, 16:38Joseph R. Shaw: Risk Stratification is Only Useful if It is Practical, Consistent, and Easy to Apply at the Bedside
-
May 9, 2026, 16:11Milad Abdalla: When 180,000 Becomes 45,000 – The EDTA Trap
-
May 9, 2026, 16:10Gertrud U. Rey: Describing the Mechanism That Causes VITT
-
May 9, 2026, 16:09Dima Shulkin: The Earliest Warning Sign of a Severe Heart Attack May Already Be in the CBC
-
May 9, 2026, 16:08Luisanna M. Sánchez: Selected for the ASH Clinical Research Training Institute
-
May 9, 2026, 16:07Maha Othman: Key Highlights from Southern Ontario Reproductive Biology
-
May 9, 2026, 15:36Rami Z. Morsi: Advancing the Full Spectrum of Stroke Care at UCM 2026 3rd Annual Stroke Symposium
-
May 9, 2026, 15:34Recognizing the Essential Role of Psychosocial Care within Bleeding Disorders Care – EAHAD
-
May 9, 2026, 15:27Abdulrahman Nasiri: How AI and Deep Learning May Help Reshape the Future of Thalassaemia Care